X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
index medicus (58) 58
male (56) 56
adult (55) 55
female (53) 53
hiv infections - complications (51) 51
hcv (49) 49
middle aged (48) 48
hcv/hiv coinfection (47) 47
hiv (47) 47
infectious diseases (45) 45
hepatitis c (44) 44
hepatitis c virus (40) 40
hepatitis c - complications (32) 32
human-immunodeficiency-virus (32) 32
virology (29) 29
hepatitis c - drug therapy (26) 26
ribavirin (26) 26
virus diseases (26) 26
antiviral agents - therapeutic use (25) 25
hiv infections - drug therapy (25) 25
immunology (23) 23
treatment outcome (23) 23
gastroenterology & hepatology (22) 22
interferon (22) 22
genotype (21) 21
hepacivirus - genetics (21) 21
hepatitis c, chronic - drug therapy (21) 21
comorbidity (20) 20
hepatitis c - virology (20) 20
hiv infections - virology (20) 20
hcv-hiv coinfection (19) 19
infected patients (19) 19
therapy (19) 19
hepatitis c, chronic - complications (18) 18
hcv/hiv co-infection (17) 17
hepatitis (17) 17
hiv infection (17) 17
coinfection (16) 16
hiv coinfection (16) 16
human immunodeficiency virus--hiv (16) 16
infection (16) 16
antiretroviral therapy (15) 15
care and treatment (15) 15
health aspects (15) 15
hepatitis-c virus (15) 15
microbiology (15) 15
ribavirin - therapeutic use (15) 15
analysis (14) 14
infections (14) 14
interferon-alpha - therapeutic use (14) 14
liver (14) 14
liver fibrosis (14) 14
digestive system diseases (13) 13
hiv infections - immunology (13) 13
risk factors (13) 13
aged (12) 12
chronic hepatitis-c (12) 12
disease (12) 12
hepacivirus - drug effects (12) 12
hepatitis c, chronic - virology (12) 12
mortality (12) 12
pegylated interferon (12) 12
viral load (12) 12
antiviral agents (11) 11
article (11) 11
coinfection - virology (11) 11
epidemiology (11) 11
genotypes (11) 11
liver-disease (11) 11
prevalence (11) 11
ribavirin - administration & dosage (11) 11
rna (11) 11
rna, viral - blood (11) 11
sofosbuvir (11) 11
sustained virologic response (11) 11
antiviral agents - administration & dosage (10) 10
drug therapy (10) 10
hepatitis c - immunology (10) 10
liver diseases (10) 10
patients (10) 10
polyethylene glycols - therapeutic use (10) 10
recombinant proteins (10) 10
retrospective studies (10) 10
sustained virological response (10) 10
virus-infection (10) 10
viruses (10) 10
combination therapy (9) 9
drug therapy, combination (9) 9
hepacivirus - isolation & purification (9) 9
hepatitis c - epidemiology (9) 9
hepatitis c, chronic - immunology (9) 9
human immunodeficiency virus (9) 9
progression (9) 9
active antiretroviral therapy (8) 8
alpha-2a plus ribavirin (8) 8
biopsy (8) 8
cirrhosis (8) 8
cohort studies (8) 8
coinfection - drug therapy (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0173943
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e86964
The pathogenesis of accelerated liver damage in subjects coinfected with hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) remains... 
CXCL10 | CELLS | INJECTION-DRUG USERS | DISEASES | HEPATITIS-C VIRUS | HCV/HIV COINFECTION | MULTIDISCIPLINARY SCIENCES | LIVER FIBROSIS | HUMAN-IMMUNODEFICIENCY-VIRUS | EXPRESSION | Liver - virology | Liver - pathology | Demography | Humans | Middle Aged | Hepatocytes - pathology | Male | Hepatocytes - metabolism | RNA, Messenger - metabolism | Young Adult | Inflammation Mediators - metabolism | Adult | Female | Hepatitis C - complications | Receptors, CXCR3 - metabolism | HIV Infections - genetics | HIV Infections - virology | Liver - metabolism | RNA, Messenger - genetics | Gene Expression Regulation | Hepatitis C - genetics | Chemokines - genetics | Coinfection - virology | Coinfection - genetics | Adolescent | HIV Infections - complications | Hepatitis C - virology | Lipopolysaccharides - pharmacology | Hepatocytes - virology | Aged | Chemokines - metabolism | Cohort Studies | Autoimmunity | Antiviral agents | Liver diseases | Cytokines | Comorbidity | Genes | Development and progression | Inflammation | HIV (Viruses) | Gene expression | Infection | Viral proteins | Hepatitis C virus | Health aspects | Pathogenesis | Liver | Gene regulation | Trafficking | Viruses | Infections | Hepatitis | Receptors | Microorganisms | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Protein transport | Immune system | Translocation | Immune response | CXCR3 protein | Polymerase chain reaction | Molecular modelling | Hepatocytes | Biopsy | Interferon | Hepatitis C | Autoimmune diseases | Alternations | Chemokines | Viral infections | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 11/2007, Volume 79, Issue 11, pp. 1679 - 1685
Journal Article
Gut and liver, ISSN 1976-2283, 11/2018, Volume 12, Issue 6, pp. 694 - 703
Journal Article
OPEN FORUM INFECTIOUS DISEASES, ISSN 2328-8957, 2017, Volume 4, Issue 3, p. ofx158
Current hepatitis C virus (HCV) treatment guidelines recommend treating HCV/human immunodeficiency virus (HIV)-coinfected individuals similar to... 
HCV treatment | HCV/HIV coinfection | INFECTIOUS DISEASES | DAA | chronic hepatitis C | MICROBIOLOGY | IMMUNOLOGY
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 694
Background/Aims: Limited data exist comparing the safety and efficacy of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) monoinfected and HCV/human... 
Sustained Virologic response | HCV/HIV coinfection | Direct acting antiviral agents | Hepatitis C | chronic
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 694
Background/Aims: Limited data exist comparing the safety and efficacy of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) monoinfected and HCV/human... 
Sustained Virologic response | HCV/HIV coinfection | Direct acting antiviral agents | Hepatitis C | chronic
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 694
Background/Aims: Limited data exist comparing the safety and efficacy of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) monoinfected and HCV/human... 
Hepatitis C | chronic; Direct acting antiviral agents; Sustained Virologic response; HCV/HIV coinfection
Journal Article
Gut and Liver, ISSN 1976-2283, 2018, Volume 12, Issue 6, p. 694
Background/Aims: Limited data exist comparing the safety and efficacy of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) monoinfected and HCV/human... 
Sustained Virologic response | HCV/HIV coinfection | Direct acting antiviral agents | Hepatitis C | chronic
Journal Article
Acta medica Indonesiana, ISSN 0125-9326, 04/2019, Volume 51, Issue 2, p. 128
HIV infection in HCV-infected patients accelerates disease progression and reduces the success rate of Peg-IFN/RBV treatment. HCV mutation in NS5A-ISDR/PKR-BD... 
NS5A-ISDR/PKR-BD | SNP IL-28B | nonneutral mutation | SVR | HCV-HIV coinfection
Journal Article
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 08/2015, Volume 212, Issue 3, pp. 367 - 377
Journal Article
Annals of Clinical Microbiology and Antimicrobials, ISSN 1476-0711, 09/2005, Volume 4, Issue 1, pp. 13 - 13
Journal Article